Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS)

CUSIP: 00461U105

Q4 2021 13F Holders as of 31 Dec 2021

Holder snapshot 7 signals
Share change
-1,869,974
Put/Call ratio
0%
SEC-reported price per share
$14.54
Number of holders
133
Value change
-$39,784,690
Number of buys
72
Open additional details 1 more signal available
Number of sells
56
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
138,752,791

Security key

00461U105

Report period

Q4 2021

Institutions

133

Top holders

10

Ownership snapshot

Top reported holders of ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
WELLINGTON MANAGEMENT GRO...
Disclosed value leader
WELLINGTON MANAGEMENT GRO...
Comparable rows
15/15
Latest evidence
30 Sep 2021
13F 3/4/5 Lead comparable stake: 3.9% Showing 1-6 of 15 holder rows.

Quick read

WELLINGTON MANAGEMENT GROUP LLP leads the comparable SEC ownership view at 3.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WELLINGTON MANAGEMENT GROUP LLP's linked filing trail.
Comparable ownership Top 5
WELLINGTON MANAGEMENT GROUP LLP 3.9%
Venrock Adviser, LLC 3.3%
Rock Springs Capital Management LP 2.7%
BlackRock Finance, Inc. 2.7%
Foresite Capital Management IV, LLC 2.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
3.9%
$97,568,000
5,420,453 shares
30 Sep 2021
Venrock Adviser, LLC
13F
Company
13F
3.3%
$82,151,000
4,563,962 shares
30 Sep 2021
Rock Springs Capital Management LP
13F
Company
13F
2.7%
$68,458,000
3,803,232 shares
30 Sep 2021
BlackRock Finance, Inc.
13F
Company
13F
2.7%
$68,192,000
3,788,417 shares
30 Sep 2021
Foresite Capital Management IV, LLC
13F
Company
13F
2.4%
$61,183,000
3,399,034 shares
30 Sep 2021
VANGUARD GROUP INC
13F
Company
13F
1.9%
$48,221,000
2,678,940 shares
30 Sep 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
133
Shares
56,045,310
Rows available
133
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
126
Q4 2021 holders
133
Holder diff
7
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 value Q4 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .